RELAPSED ADULT AML
Clinical trials for RELAPSED ADULT AML explained in plain language.
Never miss a new study
Get alerted when new RELAPSED ADULT AML trials appear
Sign up with your email to follow new studies for RELAPSED ADULT AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cell 'Bridge' offers new hope for tough leukemia
Disease control Recruiting nowThis study tests a new immune cell treatment called AdaptNK for people with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses specially selected natural killer cells from a donor, given after chemotherapy, to help control the…
Matched conditions: RELAPSED ADULT AML
Phase: PHASE1, PHASE2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
New drug cocktail offers hope for Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests a combination of three drugs (venetoclax, chidamide, and azacitidine) in 30 adults whose acute myeloid leukemia has returned or not responded to prior treatment. The goal is to see if this drug mix can safely achieve remission. Participants must be 18 or older, i…
Matched conditions: RELAPSED ADULT AML
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Engineered immune cells target stubborn leukemia in early safety trial
Disease control Recruiting nowThis early-phase study tests whether a special type of immune cell (CAR-T) that targets the CD19 protein is safe for people with acute myeloid leukemia (AML) that has come back or not responded to treatment. Only patients whose leukemia cells show CD19 are eligible. The main goal…
Matched conditions: RELAPSED ADULT AML
Phase: PHASE1 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
Engineered immune cells take on tough leukemia in early trial
Disease control Recruiting nowThis early-stage trial tests a new treatment called CLL-1 CAR-NK cells for adults with acute myeloid leukemia (AML) that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified to better recognize and attack leukemia cells. Th…
Matched conditions: RELAPSED ADULT AML
Phase: PHASE1 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 26, 2026 12:08 UTC